Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Published on 22 Apr 2024 on Benzinga via Yahoo Finance

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Friday, Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives, as announced in December 2023.

ASCEND-NASH is a Phase 2b, randomized, multicenter, double-blinded study with the first patient screened in August 2022 to evaluate the safety and efficacy of rencofilstat dosed for 12 months, with a target enrollment of 336 subjects.

Read the rest of the article

NASDAQ.HEPA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday? Friday,...

Benzinga via Yahoo Finance 22 Apr 2024

Insider Buying: Robert Foster Acquires 1,600 Shares of Hepion Pharmaceuticals Inc

On September 15, 2023, Robert Foster, the CEO, CSO, and Director of Hepion Pharmaceuticals Inc (N...

GuruFocus.com via Yahoo Finance 18 Sep 2023

Wall Street Analysts Think Hepion Pharmaceuticals, Inc. (HEPA) Could Surge 674.09%: Read This Before...

Hepion Pharmaceuticals, Inc. (HEPA) closed the last trading session at $7.45, gaining 2.1% over t...

Zacks via Yahoo Finance 6 Sep 2023

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket...

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket

Investing.com 23 May 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42%

Investing.com 22 May 2023

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving...

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Movin...

Investing.com 22 May 2023

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.42%

Investing.com 22 May 2023

Is Hepion Pharmaceuticals, Inc. (HEPA) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 23 Mar 2022

Has Hepion Pharmaceuticals, Inc. (HEPA) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 3 Mar 2022

Hepion's Rencofilstat Combo Shows Anti-Tumor Activity In Nonclinical Liver Cancer Study

Hepion Pharmaceuticals Inc (NASDAQ: HEPA) has announced the results of a nonclinical research stu...

Benzinga via Yahoo Finance 30 Jan 2022

News

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

NASDAQ.HEPA price evolution

Want to become a better investor?